Page last updated: 2024-11-05

xylazine and Canine Hip Dysplasia

xylazine has been researched along with Canine Hip Dysplasia in 2 studies

Xylazine: An adrenergic alpha-2 agonist used as a sedative, analgesic and centrally acting muscle relaxant in VETERINARY MEDICINE.
xylazine : A methyl benzene that is 1,3-dimethylbenzene which is substituted by a 5,6-dihydro-4H-1,3-thiazin-2-ylnitrilo group at position 2. It is an alpha2 adrenergic receptor agonist and frequently used in veterinary medicine as an emetic and sedative with analgesic and muscle relaxant properties.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Maitre, P1
Genevois, JP1
Remy, D1
Carozzo, C1
Arnault, F1
Buttin, P1
Viguier, E1
Fau, D1
Malm, S1
Strandberg, E1
Danell, B1
Audell, L1
Swenson, L1
Hedhammar, A1

Other Studies

2 other studies available for xylazine and Canine Hip Dysplasia

ArticleYear
Description of the type of chemical restraint used by French veterinarians to perform hip dysplasia screening radiographs. A retrospective study based on 3302 radiographs.
    Veterinary and comparative orthopaedics and traumatology : V.C.O.T, 2010, Volume: 23, Issue:4

    Topics: Acepromazine; Anesthesia, General; Anesthetics, General; Animals; Dogs; France; Hip Dysplasia, Canin

2010
Impact of sedation method on the diagnosis of hip and elbow dysplasia in Swedish dogs.
    Preventive veterinary medicine, 2007, Mar-17, Volume: 78, Issue:3-4

    Topics: Acepromazine; Age Factors; Animals; Butorphanol; Conscious Sedation; Diagnosis, Differential; Dogs;

2007